Carlos del Rio, MD Hubert Professor and Chair Hubert Department of Global Health Rollins School of Public Health of Emory University Atlanta, Georgia Understanding and Addressing Cultural and Socioeconomic Barriers to Effective HIV Management This program is supported by an educational grant from
30
Embed
Carlos del Rio, MD Hubert Professor and Chair Hubert Department of Global Health Rollins School of Public Health of Emory University Atlanta, Georgia Understanding.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Carlos del Rio, MDHubert Professor and ChairHubert Department of Global HealthRollins School of Public Health of Emory UniversityAtlanta, Georgia
Understanding and Addressing Cultural and Socioeconomic Barriers to Effective HIV Management
This program is supported by an educational grant from
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Faculty Disclosures
Carlos del Rio, MD, has disclosed that he has received consulting fees from Gilead Sciences and Pfizer.
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
1. CDC. HIV Surveillance Supplemental Report 2012;17(No. 4). Published December 2012.
Diagnosis of HIV Infection and Population by Race, 2010 (46 States)
Diagnosis of HIV Infection(N = 47,129)
Population, 46 States(N = 292,196,890)
*Hispanic/Latinos can be of any race.Note: Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statistically adjusted to account for reporting delays but not for incomplete reporting.
20%
2%
46%
29%
1% 1% <1%
12%
4%
65%16%
1% 1% <1%
American Indian/Alaska NativeAsianBlack/African AmericanHispanic/Latino*Native Hawaiian/otherPacific IslanderWhiteMultiple races
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
2. CDC. HIV Surveillance Supplemental Report 2012;17(No. 4). Published December 2012.
Diagnosis of HIV Infection Among MSM Aged 13-24 Yrs
*Hispanic/Latinos can be of any race.Note: Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statistically adjusted to account for reporting delays and missing risk-factor information, but not for incomplete reporting. Data exclude men who reported sexual contact with other men and injection drug use.
By Race, 2007-201046 States and 5 US Dependent Areas
American Indian/Alaska Native Asian
Black/African American
Hispanic/Latino*
Native Hawaiian/otherPacific Islander
White
Multiple races
Dia
gn
ose
s (n
)
Yr of Diagnosis2007 2008 2009 2010
5000
4500
3500
3000
2500
2000
1500
1000
500
0
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Very High Incidence of New HIV Infections in Young Black MSM HPTN 061: 1553 high-risk black MSM in 6 US cities
11% aware of HIV infection at baseline
12% received a new HIV diagnosis upon baseline testing
75% HIV negative at study entry
Incidence of new HIV infections over 1 yr of follow-up
– Entire cohort: 2.8%
– Men aged 18-30 yrs: 5.9%
– Men with STI at baseline: 6.0%
3. Koblin B, et al. IAS 2012. Abstract MOAC0106.
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
4. CDC. HIV Surveillance Supplemental Report 2012;17(No. 4). Published December 2012.
Trends in Age-Adjusted* Annual Rates of Death due to HIV Disease
*Standard: age distribution of 2000 US population.†Hispanic/Latinos can be of any race.The racial/ethnic categories other than Hispanic/Latino are all non-Hispanic/non-Latino. Note: For comparison with data for 1999 and later yrs, data for 1990-1998 were modified to account for ICD-10 rules instead of ICD-9 rules.
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Potential Barriers to Testing in Minorities
Patient-Related Factors Provider-Related Factors
Financial constraints Discomfort with healthcare Limited access HIV-related stigmatization and
discrimination Lack of knowledge about HIV/AIDS Fear of AIDS diagnosis Drug or alcohol use Mental illness
Complacency about risk Feelings of incompetence or
discomfort about high-risk behavior Missed opportunities to offer testing
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Tools to Increase HIV Testing
Opt-out testing
Incorporate testing into routine care
Use reminder mechanism to prompt testing
Increase outreach, education
Work with community business organizations that have the trust of the minority community
– eg, churches, barber shops, nail salons
Assure patients of confidentiality
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Addressing Specific Aspects of Care: Delays in Initiating HIV Care Characteristics associated with delay to HIV care or treatment
– Black,[10,11] Hispanic[12]
– No insurance[11]
– Less education[11]
Delays in HIV care > 3 mos[12]
– 56% more likely in black vs white patients
– 53% more likely in Hispanic vs white patients
Among patients with access to care, no disparity in outcomes by race, despite lower adherence in minorities[13]
10. Bhatta MP, et al. Am J Med Sci. 2010;339:133-140. 11. Anthony MN et al. AIDS Care. 2007;19:195-202. 12. Turner BJ, et al. Arch Intern Med. 2000;160:2614-2622. 13. Silverberg MJ, et al. J Gen Intern Med. 2009;24:1065-1072.
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Clinicians’ Attitudes May Result in Withholding or Delay of ART in Minorities Minority race often associated with perceived nonadherence;
may led to withholding/delay of ART[14-16]
In earlier study (1996-1998), 89% of HCPs said adherence an important factor in decision to prescribe PIs[17]
– Explained delayed use of PIs in minorities, women, poor
In MACH14, lower adherence among black patients not explained by differences in demographics, depression, or substance abuse[17]
– Possible contributing factors: mistrust of HCPs, health illiteracy, healthcare system inequities
14. Bogart LM, et al. Med Decis Making. 2001;21:28-36. 15. Thrasher AD, et al. J Acquir Immune Defic Syndr. 2008;49:84-93. 16. Simoni JM, et al. J Acquir Immune Defic Syndr. 2012;60:466-472. 17. Wong MD, et al. J Gen Intern Med. 2004;19:366-374.
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Delay of ART in Substance Abusers
18. Westergaard RP, et al. J Int AIDS Soc. 2012;15:10.
CD4+ Cell Count200 cells/mm3
CD4+ Cell Count 350 cells/mm3
Pro
vid
ers
Lik
ely
to D
efer
AR
T (
%) No injection drug use
Abstinent x 3 mos
Occasional injecting
Daily injecting
CD4+ Cell Count 500 cells/mm3
100
80
60
40
20
0
90
70
50
30
10
*
*
P = .03*
*
*
*
*P < .001
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Discrimination, Distrust, and Adherence
Responses in a midwestern survey[19]
– 71% reported discrimination in HIV treatment based on race
– 66% reported discrimination based on socioeconomics/class
HIV Cost and Services Utilization Study[20]
– 40% of respondents reported discriminatory healthcare
– 24% of respondents reported some mistrust of HCPs
Expected longevity for HIV-infected patients: 73 yrs
No differences in outcomes by demographic group
34. Moore RD, et al. Clin Infect Dis. 2012;55:1242-1251.
clinicaloptions.com/hivUnderstanding and Addressing Cultural and Socioeconomic Barriers
Conclusions
Nature of HIV epidemic continues to change
Cultural factors can significantly affect access, retention in HIV care
Culturally competent care can reduce barriers
Comprehensive HIV care improves outcomes, reduces disparities
Go Online to Earn CME Credit for This Activity on Overcoming Cultural and
Socioeconomic BarriersClinical Focus: concise online CME-certified module with large slide thumbnails paired with supporting text discussion by Carlos del Rio, MD, and interactive polling questions